Product
Simbrinza
1 clinical trial
3 indications
Indication
GlaucomaIndication
Open-AngleIndication
ocular hypertensionClinical trial
Multi-Center, Randomized, Double-Masked, Active Controlled, Parallel Group Study to Compare Perrigo's Brinzolamide/Brimonidine Ophthalmic Suspension 1% to Simbrinza® in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both EyesStatus: Completed, Estimated PCD: 2022-03-11